Patient dose reduction by changing the amount of 18F-FDG radiopharmaceutical injected

Authors

  • Fernanda Guerra Paiva Federal University of Minas Gerais
  • Priscilla Carmo Santana Universidade Federal de Minas Gerais
  • Arnaldo Prata Mourão Filho Centro Federal de Educação Tecnológica de Minas Gerais

DOI:

https://doi.org/10.15392/bjrs.v7i2A.704

Keywords:

PET-CT, 18F-FDG, Effective Dose

Abstract

Images of Positron Emission Tomography (PET) associated with Computed Tomography (CT) have important diagnostic applications, mainly for oncology. These compound tomographic devices allow the overlapping of functional images obtained from the administration of radiopharmaceuticals and anatomical images generated by X-ray beam attenuation. This work evaluated the impact of reducing the effective dose by reducing the activity injected into the patient using the ICRP 106 biokinetic model. The activity to be injected may vary according to the patient mass and the detector sensitivity. In this work was used the fixed mass of Alderson phantoms, as a standard adult, this mass is 73.5 kg for the male, and 50 kg for the female. Different values of activity to be injected were simulated, from 0.07 mCi to 0.15 mCi per kg, and with 10 mCi fixed, protocol used in some services. Thus, for the acquisition of PET scans, any reduction of the administered activity implies a proportional reduction of the effective dose in patient. The effective dose may vary up to 114% altering the injected activity between 0.07 and 0.15 mCi. The fixed value of 10 mCi is between these variations. It is expected that the PET/CT scans protocols are changed at the end of the study, so that the absorbed and effective dose received by the patient decreases.

Downloads

Download data is not yet available.

Author Biographies

Priscilla Carmo Santana, Universidade Federal de Minas Gerais

Departamento de anatomia e imagem

Arnaldo Prata Mourão Filho, Centro Federal de Educação Tecnológica de Minas Gerais

Departamento de Engenharia Biomédica

References

CZERNIN, J; SCHELBERT, H. PET/CT imaging: facts, opinions, hopes, and ques-tions. Journal of Nuclear Medicine, v. 45, n. 1 suppl, p. 1S-3S, 2004.

HAINER, J. General concepts of PET and PET/CT imaging. Case-Based Approach to PET/CT in Oncology, ed. Victor H. Gerbaudo. Published by Cambridge University Press. Cambrid-ge University Press 2012.

BAR-SHALOM, R. et al. Clinical performance of PET/CT in evaluation of cancer: addition-al value for diagnostic imaging and patient management. Journal of nuclear medicine, v. 44, n. 8, p. 1200-1209, 2003.

FLUX, Glenn et al. The impact of PET and SPECT on dosimetry for targeted radionuclide therapy. Zeitschrift für Medizinische Physik, v. 16, n. 1, p. 47-59, 2006.

CZERNIN, J.; ALLEN-AUERBACH, M.; SCHELBERT, H.R. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. Journal of Nuclear Medi-cine, v. 48, n. 1 suppl, p. 78S-88S, 2007.

GAMBHIR, Sanjiv S. et al. A tabulated summary of the FDG PET literature. Journal of nuclear medicine, v. 42, n. 5 suppl, p. 1S-93S, 2001.

HUANG, Bingsheng; LAW, Martin Wai-Ming; KHONG, Pek-Lan. Whole-body PET/CT scanning estimation of radiation dose and cancer risk. Radiology, v. 251, n. 1, p. 166-174, 2009.

CAMARGO, Edwaldo E. Experiência inicial com PET/CT. Radiologia Brasileira, v. 38, n. 1, p. 0-0, 2005.

QUINN, Brian et al. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates. BMC medical imaging, v. 16, n. 1, p. 41, 2016.

OLIVEIRA, S.M.V. et al. Protocol for 18F-FDG quantification in pet-ct whole-body ex-ams. Thyroid, v. 20, n. 4.3, p. 0.6, 2010.

ROBILOTTA, Cecil Chow. A tomografia por emissão de pósitrons: uma nova modalidade na medicina nuclear brasileira. Panam Salud Publica, v. 20, n. 2/3, p. 135, 2006.

NAGAKI, A.; ONOGUCHI, M.; MATSUTOMO, N. Patient Weight–Based Acquisition Protocols to Optimize18F-FDG PET/CT Image Quality. Journal of nuclear medicine technology, v. 39, n. 2, p. 72-76, 2011.

ALESSIO, A. M. et al. Weight-based, low-dose pediatric whole-body PET/CT proto-cols. Journal of Nuclear Medicine, v. 50, n. 10, p. 1570-1578, 2009.

OLIVEIRA, Cássio Miri et al. Suggestion of a national diagnostic reference level for 18F-FDG/PET scans in adult cancer patients in Brazil. Radiologia Brasileira, v. 46, n. 5, p. 284-289, 2013.

ICRP- INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTION. The 2007 Recommendations of the International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals. ICRP, Publication 106, 2008.

RADPRO, Radiation Protection for the Radiation Professionals. Avaible at: <https://www.radpro-int.com/>. Last accessed: 29 Nov. 2017.

Published

2019-02-25

How to Cite

Paiva, F. G., Santana, P. C., & Mourão Filho, A. P. (2019). Patient dose reduction by changing the amount of 18F-FDG radiopharmaceutical injected. Brazilian Journal of Radiation Sciences, 7(2A (Suppl.). https://doi.org/10.15392/bjrs.v7i2A.704

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)